Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cigarette smoking and addiction.

C Cohen1, W B Pickworth, J E Henningfield

  • 1Addiction Research Center, National Institute on Drug Abuse, Baltimore, Maryland.

Clinics in Chest Medicine
|December 1, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Does the density of lymphatic vascular space invasion affect the prognosis of stage Ib and IIA node negative carcinoma of the cervix?

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society·2003
Same author

SSR591813, a novel selective and partial alpha4beta2 nicotinic receptor agonist with potential as an aid to smoking cessation.

The Journal of pharmacology and experimental therapeutics·2003
Same author

Refinement of the Episkin protocol for the assessment of acute skin irritation of chemicals: follow-up to the ECVAM prevalidation study.

Toxicology in vitro : an international journal published in association with BIBRA·2002
Same author

SR141716, a central cannabinoid (CB(1)) receptor antagonist, blocks the motivational and dopamine-releasing effects of nicotine in rats.

Behavioural pharmacology·2002
Same author

Hepatocellular carcinoma and markers of apoptosis (bcl-2, bax, bcl-x): prognostic significance.

Applied immunohistochemistry & molecular morphology : AIMM·2002
Same author

Crystallographic findings on the internally uncoupled and near-rigor states of myosin: further insights into the mechanics of the motor.

Proceedings of the National Academy of Sciences of the United States of America·2002

Tobacco addiction is a drug addiction driven by nicotine, leading to consistent use and withdrawal symptoms. Treatment strategies for tobacco dependence mirror those for other addictions, emphasizing behavioral interventions.

Area of Science:

  • Pharmacology
  • Addiction Science
  • Neuroscience

Background:

  • Tobacco use is a significant public health issue, characterized as a form of drug addiction.
  • Nicotine, a psychoactive component of tobacco smoke, is a primary driver of this addiction.
  • The abuse liability of tobacco and nicotine has been extensively studied in both human and animal models.

Purpose of the Study:

  • To elucidate the mechanisms underlying tobacco addiction.
  • To compare tobacco addiction treatment strategies with those for other substance use disorders.
  • To highlight the role of nicotine concentration and non-pharmacologic factors in maintaining tobacco dependence.

Main Methods:

  • Review of existing scientific literature on tobacco and nicotine abuse liability.

Related Experiment Videos

  • Analysis of studies investigating nicotine self-administration in humans and animals.
  • Examination of factors contributing to tobacco dependence and cessation challenges.

    • Main Results:

    • Tobacco experimentation often escalates to consistent daily use, regulated by nicotine blood concentrations.
    • Nicotine acts as a euphoriant, leading to self-administration and behavioral control.
    • Cessation attempts can trigger withdrawal symptoms including irritability, cognitive deficits, and weight gain.
    • Non-pharmacologic factors significantly impact the success of quitting tobacco.

    Conclusions:

    • Tobacco addiction is a complex condition comparable to other drug addictions.
    • Effective treatment requires strategies addressing both pharmacologic and non-pharmacologic aspects.
    • Behavioral interventions are crucial components of tobacco addiction treatment, irrespective of medication use.
    • Future therapies may involve nicotine alternatives, antagonists, or symptom-specific medications.